Cerence (CRNC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
3 Feb, 2026Executive summary
Annual Meeting of Stockholders scheduled for February 12, 2026, to be held virtually at 11:00 a.m. Eastern Time.
Stockholders are asked to support Proposal 2, a non-binding advisory vote on executive compensation for fiscal year 2025.
Say-on-pay approval has ranged from 92% to 97% since 2022, reflecting strong alignment of pay with performance.
Glass Lewis recommends a vote FOR the say-on-pay proposal, while ISS recommends AGAINST, citing concerns over compensation metrics and targets.
Voting matters and shareholder proposals
Proposal 2 seeks approval, on an advisory basis, of named executive officers' fiscal year 2025 compensation.
Stockholders are encouraged to reconsider votes if previously cast against Proposal 2, with the ability to change votes before the meeting.
Board of directors and corporate governance
The Compensation Committee follows a rigorous process to set goals for both short- and long-term incentive plans, with input from investors.
The Board remains committed to ongoing evaluation and improvement of executive compensation, informed by regular stockholder discussions.
Latest events from Cerence
- Q2 FY25 revenue and profit exceeded guidance, with strong margins and raised outlook.CRNC
Q2 20259 Jul 2026 - Q1 revenue up 126% to $115.1M, record free cash flow, and patent settlement boost outlook.CRNC
Q1 20269 Jul 2026 - LLMs are transforming in-car voice AI, fueling growth, profitability, and new revenue streams.CRNC
28th Annual Needham Growth Conference Virtual8 Jul 2026 - XUI launch and deeper OEM integration drive growth in AI-powered automotive voice solutions.CRNC
Global Automotive OEM, Dealer & Supplier Conference8 Jul 2026 - Conversational AI drives 50% of global auto production, with FY26 revenue guided at $305M–$320M.CRNC
Investor presentation31 May 2026 - Q2 FY26 beat guidance, xUI adoption grew, and full-year outlook was raised despite lower margins.CRNC
Q2 20268 May 2026 - All director nominees and proposals were approved, with no shareholder questions submitted.CRNC
AGM 202612 Feb 2026 - Q3 revenue up 14% year-over-year; $357M goodwill impairment drives large net loss.CRNC
Q3 20242 Feb 2026 - FY24 revenue beat guidance, but goodwill impairment drove a large net loss.CRNC
Q4 202412 Jan 2026